• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤稿通知：在接受透析或严重慢性肾脏病的患者中使用钆贝葡胺后未发生肾源性系统纤维化。

Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease.

机构信息

From the Department of Medical Imaging, University of Arizona College of Medicine, Banner University Medical Center, 1501 N Campbell Ave, PO Box 245067 Tucson, AZ 85724 (D.R.M., B.K., K.S., S.V.); and Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Ga (A.M., P.K.M.).

出版信息

Radiology. 2018 Jan;286(1):113-119. doi: 10.1148/radiol.2017170102. Epub 2017 Jul 21.

DOI:10.1148/radiol.2017170102
PMID:28731375
Abstract

The authors have requested to withdraw this manuscript from publication because the study was not conducted in full accordance with the relevant institutional IRB protocol. RSNA, 2018.

摘要

作者要求撤回该稿件，因为该研究未完全按照相关机构的 IRB 协议进行。RSNA，2018.

相似文献

1
Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease.撤稿通知：在接受透析或严重慢性肾脏病的患者中使用钆贝葡胺后未发生肾源性系统纤维化。
Radiology. 2018 Jan;286(1):113-119. doi: 10.1148/radiol.2017170102. Epub 2017 Jul 21.
2
Gadobenate Dimeglumine Administration and Nephrogenic Systemic Fibrosis: Is There a Real Risk in Patients with Impaired Renal Function?钆贝葡胺给药与肾源性系统性纤维化：肾功能受损患者存在真实风险吗？
Radiology. 2015 Sep;276(3):741-7. doi: 10.1148/radiol.2015142423. Epub 2015 Apr 15.
3
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.对接受注射钆贝葡胺或钆特醇磁共振成像检查的3 - 5期慢性肾脏病患者进行的肾源性系统性纤维化前瞻性队列研究。
AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.
4
Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI.对中度肾功能不全患者静脉注射钆贝葡胺进行磁共振成像（MRI）检查时发生肾源性系统性纤维化的发生率评估。
Clin Radiol. 2009 Jul;64(7):706-13. doi: 10.1016/j.crad.2009.04.004. Epub 2009 May 26.
5
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.肾源性系统性纤维化：钆造影剂更换和采用钆造影剂政策后发病率的变化——来自两所美国大学的报告。
Radiology. 2009 Dec;253(3):689-96. doi: 10.1148/radiol.2533090649. Epub 2009 Sep 29.
6
Renal Safety of Intravenous Gadolinium-enhanced MRI in Patients Following Liver Transplantation.肝移植后患者静脉内钆增强 MRI 的肾脏安全性。
Transplantation. 2019 Jun;103(6):e159-e163. doi: 10.1097/TP.0000000000002678.
7
Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide.与钆双胺相比，1423例肾功能不全患者使用钆贝葡胺后发生肾源性系统性纤维化的发生率
Invest Radiol. 2016 Nov;51(11):701-705. doi: 10.1097/RLI.0000000000000259.
8
Incidence of immediate gadolinium contrast media reactions.即刻型钆对比剂不良反应发生率。
AJR Am J Roentgenol. 2011 Feb;196(2):W138-43. doi: 10.2214/AJR.10.4885.
9
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.接受 II 类钆基造影剂的 4 或 5 期慢性肾脏病患者发生肾源性系统纤维化的风险：系统评价和荟萃分析。
JAMA Intern Med. 2020 Feb 1;180(2):223-230. doi: 10.1001/jamainternmed.2019.5284.
10
Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study.钆喷酸葡胺在35499例患者中的安全性观察研究：SECURE研究
J Magn Reson Imaging. 2017 Apr;45(4):988-997. doi: 10.1002/jmri.25486. Epub 2016 Oct 11.

引用本文的文献

1
Gadolinium-based contrast agents: why nephrologists need to be concerned.镧系元素类造影剂：肾科医生为何需关注此类药物。
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):154-162. doi: 10.1097/MNH.0000000000000475.
2
Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.基于钆的造影剂在肾脏疾病中的应用：加拿大放射学会发布的综合综述与临床实践指南
Can J Kidney Health Dis. 2018 Jun 12;5:2054358118778573. doi: 10.1177/2054358118778573. eCollection 2018.
3
Clinical application and technical considerations of T & T(*) mapping in cardiac, liver, and renal imaging.
T&T（*）映射在心脏、肝脏和肾脏成像中的临床应用及技术考量
Br J Radiol. 2018 Dec;91(1092):20170825. doi: 10.1259/bjr.20170825. Epub 2018 Jul 23.
4
10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.10 年肾源性系统性纤维化：对 2006 年至 2016 年期间一家制药公司收到的肾源性系统性纤维化报告的综合分析。
Invest Radiol. 2018 Sep;53(9):541-550. doi: 10.1097/RLI.0000000000000462.
5
Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.多次注射钆贝葡胺后苍白球和齿状核内出现高信号强度。
AJNR Am J Neuroradiol. 2018 Mar;39(3):415-420. doi: 10.3174/ajnr.A5510. Epub 2018 Jan 18.
6
Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.基于大环的系列对比剂钆喷酸葡胺和钆布醇给药对未增强T1加权脑内钆相关齿状核信号增加的影响：一项对158例多发性硬化（MS）患者的回顾性研究
Radiol Med. 2018 Feb;123(2):125-134. doi: 10.1007/s11547-017-0816-9. Epub 2017 Sep 27.